nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PTGDR2—brain—conduct disorder	0.0313	0.16	CbGeAlD
Indomethacin—CES1—E2F transcription factor network—WASF1—conduct disorder	0.026	0.0323	CbGpPWpGaD
Indomethacin—UGT2B7—Estrogen metabolism—COMT—conduct disorder	0.0258	0.032	CbGpPWpGaD
Indomethacin—UGT1A1—Estrogen metabolism—COMT—conduct disorder	0.0209	0.026	CbGpPWpGaD
Indomethacin—UGT1A9—Estrogen metabolism—COMT—conduct disorder	0.0209	0.026	CbGpPWpGaD
Indomethacin—PTGR2—brain—conduct disorder	0.0208	0.106	CbGeAlD
Indomethacin—CXCL8—Glucocorticoid receptor regulatory network—CGA—conduct disorder	0.0204	0.0253	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0179	0.0223	CbGpPWpGaD
Indomethacin—PPARA—Orphan transporters—GABRA2—conduct disorder	0.0174	0.0216	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—CGA—conduct disorder	0.0136	0.0169	CbGpPWpGaD
Indomethacin—GLO1—brain—conduct disorder	0.0128	0.0657	CbGeAlD
Indomethacin—PTGDR2—G alpha (i) signalling events—DRD4—conduct disorder	0.0126	0.0157	CbGpPWpGaD
Indomethacin—ABCC11—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0125	0.0156	CbGpPWpGaD
Indomethacin—PLA2G2A—brain—conduct disorder	0.0119	0.0611	CbGeAlD
Indomethacin—CXCL8—brain—conduct disorder	0.0118	0.0604	CbGeAlD
Indomethacin—PTGDR2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0117	0.0145	CbGpPWpGaD
Indomethacin—PPARA—REV-ERBA represses gene expression—EP300—conduct disorder	0.0116	0.0144	CbGpPWpGaD
Indomethacin—PPARA—RORA activates circadian gene expression—EP300—conduct disorder	0.0112	0.0139	CbGpPWpGaD
Indomethacin—PPARA—brain—conduct disorder	0.0111	0.057	CbGeAlD
Indomethacin—CES1—NRF2 pathway—SLC6A4—conduct disorder	0.0111	0.0138	CbGpPWpGaD
Indomethacin—SLC10A1—brain—conduct disorder	0.0107	0.0548	CbGeAlD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.01	0.0125	CbGpPWpGaD
Indomethacin—SLC22A7—brain—conduct disorder	0.00954	0.0489	CbGeAlD
Indomethacin—ABCC6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00949	0.0118	CbGpPWpGaD
Indomethacin—AKR1C3—brain—conduct disorder	0.00925	0.0474	CbGeAlD
Indomethacin—SLC22A6—brain—conduct disorder	0.00921	0.0472	CbGeAlD
Indomethacin—CES1—brain—conduct disorder	0.00826	0.0423	CbGeAlD
Indomethacin—PPARA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—conduct disorder	0.00819	0.0102	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—CGA—conduct disorder	0.00771	0.00958	CbGpPWpGaD
Indomethacin—PTGDR2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00764	0.00949	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—DRD4—conduct disorder	0.00764	0.00949	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0075	0.00932	CbGpPWpGaD
Indomethacin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—conduct disorder	0.00745	0.00926	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00725	0.00901	CbGpPWpGaD
Indomethacin—UGT2B7—Phase II conjugation—COMT—conduct disorder	0.00724	0.009	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—CGA—conduct disorder	0.007	0.0087	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00698	0.00867	CbGpPWpGaD
Indomethacin—ABCC3—brain—conduct disorder	0.00673	0.0345	CbGeAlD
Indomethacin—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.00667	0.00829	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00654	0.00813	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—SLC6A4—conduct disorder	0.00651	0.00809	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00638	0.00792	CbGpPWpGaD
Indomethacin—ABCC3—NRF2 pathway—SLC6A4—conduct disorder	0.00637	0.00792	CbGpPWpGaD
Indomethacin—UGT2B7—NRF2 pathway—SLC6A4—conduct disorder	0.00637	0.00792	CbGpPWpGaD
Indomethacin—AKR1C3—Metapathway biotransformation—COMT—conduct disorder	0.00636	0.0079	CbGpPWpGaD
Indomethacin—CES1—E2F transcription factor network—EP300—conduct disorder	0.00628	0.0078	CbGpPWpGaD
Indomethacin—PPARG—brain—conduct disorder	0.00612	0.0314	CbGeAlD
Indomethacin—PPARA—Circadian rythm related genes—DRD4—conduct disorder	0.00612	0.00761	CbGpPWpGaD
Indomethacin—ABCC4—NRF2 pathway—SLC6A4—conduct disorder	0.00599	0.00744	CbGpPWpGaD
Indomethacin—PPARA—Circadian Clock—EP300—conduct disorder	0.00597	0.00741	CbGpPWpGaD
Indomethacin—UGT1A1—Phase II conjugation—COMT—conduct disorder	0.00588	0.00731	CbGpPWpGaD
Indomethacin—UGT1A9—Phase II conjugation—COMT—conduct disorder	0.00588	0.00731	CbGpPWpGaD
Indomethacin—SLCO1A2—brain—conduct disorder	0.00578	0.0296	CbGeAlD
Indomethacin—ALB—brain—conduct disorder	0.00574	0.0294	CbGeAlD
Indomethacin—ABCC4—brain—conduct disorder	0.00556	0.0285	CbGeAlD
Indomethacin—SLC22A8—brain—conduct disorder	0.00552	0.0283	CbGeAlD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00548	0.00681	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00546	0.00678	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—CGA—conduct disorder	0.00531	0.0066	CbGpPWpGaD
Indomethacin—PTGS1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00524	0.00652	CbGpPWpGaD
Indomethacin—UGT1A1—NRF2 pathway—SLC6A4—conduct disorder	0.00518	0.00643	CbGpPWpGaD
Indomethacin—UGT1A9—NRF2 pathway—SLC6A4—conduct disorder	0.00518	0.00643	CbGpPWpGaD
Indomethacin—CXCL8—ATF-2 transcription factor network—EP300—conduct disorder	0.00513	0.00638	CbGpPWpGaD
Indomethacin—ABCC2—NRF2 pathway—SLC6A4—conduct disorder	0.00505	0.00628	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—HTR2A—conduct disorder	0.00498	0.00619	CbGpPWpGaD
Indomethacin—CXCL8—G alpha (i) signalling events—DRD4—conduct disorder	0.00491	0.00611	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00475	0.00591	CbGpPWpGaD
Indomethacin—ABCC1—brain—conduct disorder	0.00474	0.0243	CbGeAlD
Indomethacin—PPARG—Circadian rythm related genes—SLC6A4—conduct disorder	0.00467	0.0058	CbGpPWpGaD
Indomethacin—PPARA—Transcriptional regulation of white adipocyte differentiation—EP300—conduct disorder	0.00456	0.00566	CbGpPWpGaD
Indomethacin—CXCL8—AP-1 transcription factor network—EP300—conduct disorder	0.00448	0.00556	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00445	0.00553	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—DRD4—conduct disorder	0.00439	0.00545	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—DRD4—conduct disorder	0.00432	0.00536	CbGpPWpGaD
Indomethacin—PPARA—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00424	0.00527	CbGpPWpGaD
Indomethacin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00424	0.00527	CbGpPWpGaD
Indomethacin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00424	0.00527	CbGpPWpGaD
Indomethacin—UGT2B7—Biological oxidations—COMT—conduct disorder	0.00424	0.00526	CbGpPWpGaD
Indomethacin—UGT2B7—Biological oxidations—MAOA—conduct disorder	0.00421	0.00523	CbGpPWpGaD
Indomethacin—UGT2B7—Metapathway biotransformation—COMT—conduct disorder	0.00418	0.00519	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CGA—conduct disorder	0.00413	0.00514	CbGpPWpGaD
Indomethacin—SLC22A11—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00413	0.00513	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—conduct disorder	0.00402	0.005	CbGpPWpGaD
Indomethacin—CXCL8—Glucocorticoid receptor regulatory network—EP300—conduct disorder	0.00394	0.0049	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—DRD4—conduct disorder	0.00392	0.00487	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00391	0.00486	CbGpPWpGaD
Indomethacin—SLC22A7—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00375	0.00466	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—CGA—conduct disorder	0.00374	0.00464	CbGpPWpGaD
Indomethacin—PPARG—Regulation of retinoblastoma protein—EP300—conduct disorder	0.0037	0.00459	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0036	0.00448	CbGpPWpGaD
Indomethacin—PPARG—Signaling events mediated by HDAC Class I—EP300—conduct disorder	0.00353	0.00438	CbGpPWpGaD
Indomethacin—UGT1A9—Biological oxidations—COMT—conduct disorder	0.00344	0.00428	CbGpPWpGaD
Indomethacin—UGT1A1—Biological oxidations—COMT—conduct disorder	0.00344	0.00428	CbGpPWpGaD
Indomethacin—PPARA—PPARA activates gene expression—EP300—conduct disorder	0.00343	0.00426	CbGpPWpGaD
Indomethacin—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.00342	0.00425	CbGpPWpGaD
Indomethacin—UGT1A9—Biological oxidations—MAOA—conduct disorder	0.00342	0.00425	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00341	0.00423	CbGpPWpGaD
Indomethacin—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.00339	0.00422	CbGpPWpGaD
Indomethacin—UGT1A9—Metapathway biotransformation—COMT—conduct disorder	0.00339	0.00422	CbGpPWpGaD
Indomethacin—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00335	0.00417	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—CGA—conduct disorder	0.00334	0.00415	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—WASF1—conduct disorder	0.00331	0.00412	CbGpPWpGaD
Indomethacin—PTGS1—brain—conduct disorder	0.00327	0.0168	CbGeAlD
Indomethacin—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—conduct disorder	0.00327	0.00406	CbGpPWpGaD
Indomethacin—ABCC3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00321	0.00399	CbGpPWpGaD
Indomethacin—SLC22A8—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00315	0.00392	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00314	0.0039	CbGpPWpGaD
Indomethacin—PTGS2—brain—conduct disorder	0.00313	0.016	CbGeAlD
Indomethacin—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00302	0.00376	CbGpPWpGaD
Indomethacin—ABCC4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00302	0.00375	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—CGA—conduct disorder	0.003	0.00373	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—DRD4—conduct disorder	0.00298	0.0037	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00293	0.00364	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—CGA—conduct disorder	0.00284	0.00353	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00282	0.00351	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—HTR2A—conduct disorder	0.00282	0.0035	CbGpPWpGaD
Indomethacin—PTGS1—Biological oxidations—COMT—conduct disorder	0.00281	0.00349	CbGpPWpGaD
Indomethacin—SLCO1A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0028	0.00348	CbGpPWpGaD
Indomethacin—PTGS1—Biological oxidations—MAOA—conduct disorder	0.00279	0.00346	CbGpPWpGaD
Indomethacin—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00276	0.00343	CbGpPWpGaD
Indomethacin—PTGS2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00274	0.00341	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CGA—conduct disorder	0.00273	0.00339	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00268	0.00333	CbGpPWpGaD
Indomethacin—SLC22A6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00263	0.00327	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—POLR3A—conduct disorder	0.00259	0.00322	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—HTR2A—conduct disorder	0.00256	0.00318	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00255	0.00317	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00255	0.00317	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00252	0.00313	CbGpPWpGaD
Indomethacin—PPARG—PPARA activates gene expression—EP300—conduct disorder	0.00246	0.00305	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—CGA—conduct disorder	0.00244	0.00303	CbGpPWpGaD
Indomethacin—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.0024	0.00299	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00239	0.00297	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00239	0.00297	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00236	0.00293	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—DRD4—conduct disorder	0.00232	0.00288	CbGpPWpGaD
Indomethacin—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00231	0.00287	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—CGA—conduct disorder	0.00212	0.00263	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—EP300—conduct disorder	0.00212	0.00263	CbGpPWpGaD
Indomethacin—UGT1A9—PPARA activates gene expression—EP300—conduct disorder	0.00211	0.00262	CbGpPWpGaD
Indomethacin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00207	0.00257	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CGA—conduct disorder	0.00204	0.00254	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—HTR2A—conduct disorder	0.00194	0.00241	CbGpPWpGaD
Indomethacin—ABCB1—brain—conduct disorder	0.00194	0.00991	CbGeAlD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00189	0.00235	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—POLR3A—conduct disorder	0.00186	0.00231	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—EP300—conduct disorder	0.00169	0.00211	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—DRD4—conduct disorder	0.00168	0.00209	CbGpPWpGaD
Indomethacin—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00166	0.00206	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—WASF1—conduct disorder	0.00164	0.00203	CbGpPWpGaD
Indomethacin—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00162	0.00201	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CGA—conduct disorder	0.00161	0.002	CbGpPWpGaD
Indomethacin—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00161	0.002	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CGA—conduct disorder	0.0016	0.00199	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CGA—conduct disorder	0.0016	0.00199	CbGpPWpGaD
Indomethacin—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.0016	0.00198	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—EP300—conduct disorder	0.00155	0.00192	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00153	0.0019	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—DRD4—conduct disorder	0.00153	0.0019	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CGA—conduct disorder	0.00152	0.00189	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—EP300—conduct disorder	0.00152	0.00188	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HTR2A—conduct disorder	0.00151	0.00188	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—COMT—conduct disorder	0.00151	0.00187	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—MAOA—conduct disorder	0.0015	0.00186	CbGpPWpGaD
Indomethacin—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00147	0.00183	CbGpPWpGaD
Indomethacin—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00146	0.00182	CbGpPWpGaD
Indomethacin—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00146	0.00181	CbGpPWpGaD
Indomethacin—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00145	0.00181	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00145	0.0018	CbGpPWpGaD
Indomethacin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00142	0.00177	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CGA—conduct disorder	0.0014	0.00174	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00138	0.00171	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00137	0.0017	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CGA—conduct disorder	0.0013	0.00162	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CGA—conduct disorder	0.0013	0.00162	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—WASF1—conduct disorder	0.00129	0.0016	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—COMT—conduct disorder	0.00128	0.00159	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—MAOA—conduct disorder	0.00127	0.00158	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CGA—conduct disorder	0.00126	0.00156	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00125	0.00156	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00123	0.00153	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0012	0.00149	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CGA—conduct disorder	0.00119	0.00148	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—DRD4—conduct disorder	0.00114	0.00142	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—COMT—conduct disorder	0.0011	0.00137	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—HTR2A—conduct disorder	0.0011	0.00136	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—MAOA—conduct disorder	0.00109	0.00136	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CGA—conduct disorder	0.00106	0.00132	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00106	0.00132	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—EP300—conduct disorder	0.00103	0.00128	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HTR2A—conduct disorder	0.000996	0.00124	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—COMT—conduct disorder	0.000956	0.00119	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—MAOA—conduct disorder	0.000949	0.00118	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00092	0.00114	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—DRD4—conduct disorder	0.000902	0.00112	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000878	0.00109	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CGA—conduct disorder	0.000844	0.00105	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—EP300—conduct disorder	0.0008	0.000994	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HTR2A—conduct disorder	0.000746	0.000927	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—EP300—conduct disorder	0.000739	0.000918	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—COMT—conduct disorder	0.000724	0.0009	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—COMT—conduct disorder	0.000724	0.0009	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—EP300—conduct disorder	0.00072	0.000895	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—MAOA—conduct disorder	0.000719	0.000894	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—MAOA—conduct disorder	0.000719	0.000894	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000697	0.000867	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—COMT—conduct disorder	0.000685	0.000851	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CGA—conduct disorder	0.000683	0.000848	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—MAOA—conduct disorder	0.00068	0.000845	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00066	0.00082	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—EP300—conduct disorder	0.000647	0.000803	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—COMT—conduct disorder	0.000631	0.000784	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—MAOA—conduct disorder	0.000626	0.000778	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000623	0.000774	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CGA—conduct disorder	0.000613	0.000762	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000607	0.000755	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CGA—conduct disorder	0.000598	0.000743	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—COMT—conduct disorder	0.000589	0.000731	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—COMT—conduct disorder	0.000589	0.000731	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HTR2A—conduct disorder	0.000589	0.000731	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—MAOA—conduct disorder	0.000584	0.000726	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—MAOA—conduct disorder	0.000584	0.000726	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—COMT—conduct disorder	0.000568	0.000705	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000567	0.000704	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—EP300—conduct disorder	0.000564	0.000701	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—MAOA—conduct disorder	0.000564	0.0007	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CGA—conduct disorder	0.000559	0.000694	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—EP300—conduct disorder	0.00055	0.000683	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000547	0.000679	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—COMT—conduct disorder	0.000539	0.00067	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—MAOA—conduct disorder	0.000536	0.000665	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000519	0.000645	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—COMT—conduct disorder	0.00048	0.000596	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—MAOA—conduct disorder	0.000476	0.000592	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—EP300—conduct disorder	0.000473	0.000587	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000462	0.000574	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—EP300—conduct disorder	0.00041	0.000509	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EP300—conduct disorder	0.000395	0.000491	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—COMT—conduct disorder	0.000381	0.000473	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MAOA—conduct disorder	0.000378	0.00047	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000367	0.000456	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—EP300—conduct disorder	0.000326	0.000405	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EP300—conduct disorder	0.000312	0.000387	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—EP300—conduct disorder	0.000311	0.000386	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—EP300—conduct disorder	0.000311	0.000386	CbGpPWpGaD
Indomethacin—ALB—Metabolism—COMT—conduct disorder	0.000308	0.000383	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MAOA—conduct disorder	0.000306	0.00038	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000297	0.000369	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—EP300—conduct disorder	0.000294	0.000365	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EP300—conduct disorder	0.000291	0.000361	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—COMT—conduct disorder	0.000277	0.000344	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MAOA—conduct disorder	0.000275	0.000341	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—EP300—conduct disorder	0.00027	0.000336	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—COMT—conduct disorder	0.00027	0.000336	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MAOA—conduct disorder	0.000268	0.000333	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000266	0.000331	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—EP300—conduct disorder	0.000252	0.000314	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—EP300—conduct disorder	0.000252	0.000314	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—COMT—conduct disorder	0.000252	0.000313	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MAOA—conduct disorder	0.00025	0.000311	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—EP300—conduct disorder	0.000243	0.000302	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000243	0.000302	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—EP300—conduct disorder	0.000231	0.000287	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—EP300—conduct disorder	0.000206	0.000256	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EP300—conduct disorder	0.000195	0.000242	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—EP300—conduct disorder	0.000163	0.000203	CbGpPWpGaD
Indomethacin—ALB—Metabolism—EP300—conduct disorder	0.000132	0.000164	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—EP300—conduct disorder	0.000119	0.000147	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—EP300—conduct disorder	0.000116	0.000144	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—EP300—conduct disorder	0.000108	0.000134	CbGpPWpGaD
